文献速递腹部儿科影像MR

儿童和年轻成人代谢功能障碍相关脂肪性肝病的纵向评估:基于MR弹性成像的定义

Longitudinal evaluation of pediatric and young adult metabolic dysfunction-associated steatotic liver disease defined by MR elastography.
PubMed 文献 · Eur Radiol · 2024-10-23

本回顾性研究纳入121例年龄<23岁的MASLD患者,于2009年9月至2022年11月期间接受系列MR弹性成像(MRE)和/或MR脂肪分数(FF)检查,以描述真实世界自然史并识别肝病进展的基线预测因素。结果显示,多数患者肝硬度或肝脂肪含量保持稳定或进展,仅少数改善;肝硬度进展与西班牙裔、基线BMI-for-age百分位、基线平均肝FF及GGT变化相关,肝FF进展的预测因素包括ALT、AST、GGT和LDL。

要点

  • 系列MRE中79%(91/114)患者肝硬度不变或恶化,系列FF中59%(52/88)患者肝脂肪不变或恶化。
  • 肝硬度进展与西班牙裔、基线BMI-for-age百分位、基线平均肝FF及GGT变化相关。
  • 肝FF进展的预测因素包括ALT、AST、GGT和LDL。

核心结论

  • 在真实世界儿童和年轻成人MASLD队列中,少数患者肝硬度或肝脂肪分数随时间改善,多数保持稳定或进展;识别出的进展风险因素可能有助于识别需要超出生活方式干预的儿童。

研究设计与样本

  • 回顾性研究,纳入2009年9月至2022年11月连续<23岁MASLD患者121例(87例男性,基线平均年龄12±3岁),共297次MRE检查,首次与末次MRE平均间隔34±24个月(范围1-120个月);采用随机截距模型描述LSM(千帕/年)和FF(百分比/年)的年变化率;LSM相对变化≥19%和FF绝对变化≥5%视为临床有意义。

诊断标准与关键数值

  • LSM相对变化≥19%和FF绝对变化≥5%视为临床有意义;114例系列LSM中33%(38/114)进展、46%(53/114)稳定、21%(23/114)消退;88例系列FF中57%(50/88)进展、2%(2/88)稳定、41%(36/88)消退。

临床应用与阅片要点

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: To inform clinical monitoring of children and young adults with metabolic dysfunction-associated steatotic liver disease (MASLD) by characterizing the real-world natural history of MASLD and identifying baseline predictors of liver disease progression.

MATERIALS AND METHODS: This retrospective study included consecutive patients ages < 23 years with MASLD who underwent serial MR elastography (MRE) and/or MR fat fraction (FF) examinations between 09/2009 and 11/2022. Outcomes of MASLD were defined based on maximum ratio values. A relative change ≥ 19% in liver stiffness measures (LSM) and an absolute change ≥ 5% for liver FF were considered clinically meaningful. Random intercept models characterized the yearly rate of change in LSM (kilopascals per year) and FF (percentage per year).

RESULTS: One hundred twenty-one patients (87 males, mean age at baseline: 12 ± 3 [SD] years) underwent 297 MRE examinations. The mean interval between the first and last MRE was 34 (± 24) months (range: 1-120 months). Among the 114 patients with serial LSM, 33% (38/114) showed progression, 46% (53/114) remained stable, and 21% (23/114) showed regression. Among the 88 patients with serial FF measures, 57% (50/88) showed progression, 2% (2/88) remained stable, and 41% (36/88) showed regression. LSM progression was associated with Hispanic ethnicity, baseline BMI-for-age percentile, baseline mean liver FF, and GGT changes over time. Predictors for liver FF progression included ALT, AST, GGT, and LDL.

CONCLUSION: In a real-world sample of children and young adults with MASLD who underwent serial liver MRI, a minority of patients demonstrated improvements in liver stiffness or FF over time.

KEY POINTS: Question In children, there is scarce data regarding the natural history of MASLD. Findings In this retrospective study, most children and young adults with MASLD had either unchanged or worsening liver stiffness (n = 91/114, 79%) and liver fat (n = 52/88, 59%). Clinical relevance Our findings emphasize the need for optimized care in pediatric MASLD. The identified risk factors for the progression of liver fat and stiffness may help to identify children who require interventions beyond changes in lifestyle.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Alves VPV, Mouzaki M, Xanthakos SA, et al. Longitudinal evaluation of pediatric and young adult metabolic dysfunction-associated steatotic liver disease defined by MR elastography. Eur Radiol. 2024. PMID: 39438331. doi:10.1007/s00330-024-11146-z

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。